Timing of Bisphosphonate (Alendronate) Initiation after Surgery for Fragility Fracture: A Population-Based Cohort Study
Bisphosphonates are used as first-line treatment for the prevention of fragility fracture (FF); they act by inhibiting osteoclast-mediated bone resorption. The timing of their administration after FF surgery is controversial; thus, we compared the incidence of second FF, surgery for second FF, and a...
Main Authors: | Meng-Huang Wu, Yu-Sheng Lin, Christopher Wu, Ching-Yu Lee, Yi-Chia Chen, Tsung-Jen Huang, Jur-Shan Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/12/2541 |
Similar Items
-
Fragility Fractures: Risk Factors and Management in the Elderly
by: Filippo Migliorini, et al.
Published: (2021-10-01) -
Augmentation in fragility fractures, bone of contention: a systematic review
by: Eleonora Piccirilli, et al.
Published: (2022-12-01) -
Fragility Fractures and Imminent Fracture Risk in the Spanish Population: A Retrospective Observational Cohort Study
by: Maria-José Montoya-García, et al.
Published: (2021-03-01) -
Atraumatic isolated bilateral fibular shaft fragility fracture: A rare case
by: Kalluraya Suryakanth, et al.
Published: (2023-01-01) -
The trend of osteoporosis and osteoporotic fragility fractures in inpatients: results from a national database
by: Rashmi Dhital, et al.
Published: (2019-05-01)